|
PPP2R2A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.522200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.223560E-01 |
| Normal-vs-Stage2 |
1.814020E-01 |
| Normal-vs-Stage3 |
8.365500E-02 |
| Normal-vs-Stage4 |
6.419700E-02 |
| Stage1-vs-Stage2 |
8.003400E-01 |
| Stage1-vs-Stage3 |
6.296200E-01 |
| Stage1-vs-Stage4 |
5.734800E-01 |
| Stage2-vs-Stage3 |
9.313600E-01 |
| Stage2-vs-Stage4 |
8.269400E-01 |
| Stage3-vs-Stage4 |
8.665200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.671500E-02 |
| Normal-vs-AfricanAmerican |
8.761400E-01 |
| Normal-vs-Asian |
5.909400E-01 |
| Caucasian-vs-AfricanAmerican |
1.602640E-01 |
| Caucasian-vs-Asian |
3.086600E-01 |
| AfricanAmerican-vs-Asian |
5.766600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.918400E-02 |
| Normal-vs-Female |
1.464200E-01 |
| Male-vs-Female |
2.054000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.245400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.071800E-02 |
| Normal-vs-Age(61-80Yrs) |
1.789630E-02 |
| Normal-vs-Age(81-100Yrs) |
3.188000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.580200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.389990E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.255200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.292800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.758600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.323400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.497800E-01 |
| Classical-VS-Follicular |
3.168300E-02 |
| Classical-VS-Other |
4.423800E-02 |
| Classical-VS-Normal |
3.126800E-01 |
| Tall-VS-Follicular |
3.009800E-01 |
| Tall-VS-Other |
1.064050E-01 |
| Tall-VS-Normal |
3.416000E-01 |
| Follicular-VS-Other |
4.340800E-01 |
| Follicular-VS-Normal |
1.330130E-02 |
| Other-VS-Normal |
1.707680E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.673510E-02 |
| Normal-vs-N1 |
7.601200E-03 |
| N0-vs-N1 |
3.411600E-01 |
|
|
